Ryohei Katoh
Overview
Explore the profile of Ryohei Katoh including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
172
Citations
2480
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yamazaki H, Sugino K, Inoue K, Katoh R, Matsuzu K, Kitagawa W, et al.
Eur Thyroid J
. 2025 Mar;
PMID: 40048251
Background This study aimed to investigate the changes in the histological types and causes of death associated with thyroid carcinoma (TC) before and after the introduction of systemic drug therapy....
2.
Yamazaki H, Sugino K, Katoh R, Matsuzu K, Kitagawa W, Nagahama M, et al.
Eur Thyroid J
. 2024 Oct;
13(5).
PMID: 39419099
Follicular thyroid carcinoma (FTC) is the second most common histological type of thyroid carcinoma. This review aims to summarize the available evidence and guidelines and provide an updated consensus regarding...
3.
Impact of the quality of resected thyroid cancer tissue sample on next-generation sequencing testing
Hatanaka K, Nakamura K, Katoh R, Ito K, Hirokawa M, Miyauchi A, et al.
Pathol Int
. 2024 Jan;
74(2):77-86.
PMID: 38226479
Activating rearranged during transfection (RET) proto-oncogene alterations can be identified using next-generation sequencing (NGS) of tumor DNA/RNA. We assessed factors associated with NGS (Oncomine Dx Target Test [ODxTT]) success for...
4.
Yamazaki H, Sugino K, Katoh R, Matsuzu K, Kitagawa W, Nagahama M, et al.
J Clin Endocrinol Metab
. 2023 Nov;
109(5):1291-1300.
PMID: 38006314
Objective: The present study investigated the prognostic factors for follicular thyroid carcinoma (FTC) with the incorporation of the histologic subtype and degree of vascular invasion (VI). Patients: The records of...
5.
Yamazaki H, Sugino K, Katoh R, Matsuzu K, Kitagawa W, Nagahama M, et al.
World J Surg
. 2023 Jul;
47(11):2767-2775.
PMID: 37516689
Background: This study aimed to investigate the association between the extent of vascular invasion (VI) and the outcome of widely invasive follicular thyroid carcinoma (WI-FTC). Methods: The records of 107...
6.
Inoue T, Ohno N, Oishi N, Mochizuki K, Katoh R, Kondo T
Pathol Int
. 2023 May;
73(8):341-350.
PMID: 37154498
Nuclear morphology of carcinoma cells is critical for the pathological diagnosis of papillary thyroid carcinoma (PTC). However, three-dimensional architecture of PTC nuclei is still elusive. In this study, we analyzed...
7.
Sugisawa C, Narumi S, Tanase-Nakao K, Hoshiyama A, Suzuki N, Ohye H, et al.
Thyroid
. 2023 Feb;
33(5):556-565.
PMID: 36792927
More than 40 years have passed since the introduction of newborn screening (NBS) for congenital hypothyroidism (CH), and many early diagnosed patients have reached adulthood. Their thyroid morphology and function...
8.
Ohkuwa K, Katoh R, Sugino K, Nagahama M, Kitagawa W, Matsuzu K, et al.
World J Surg Oncol
. 2023 Feb;
21(1):32.
PMID: 36737774
Purpose: The purpose of this study was to examine the postoperative clinical course of parathyroid carcinoma to determine factors that predict postoperative recurrence and distant metastasis. Methods: In this retrospective...
9.
Le H, Nguyen T, Hirokawa M, Katoh R, Mitsutake N, Matsuse M, et al.
Endocr Pathol
. 2022 Nov;
34(1):100-111.
PMID: 36394696
Mucoepidermoid carcinoma (MEC) and sclerosing MEC with eosinophilia (SMECE) are rare primary thyroid carcinomas. In this study, we aimed to present our multicenter series of MEC and SMECE and integrated...
10.
Yamazaki H, Katoh R, Sugino K, Matsuzu K, Masaki C, Akaishi J, et al.
Ann Surg Oncol
. 2022 Sep;
29(13):8213.
PMID: 36138288
No abstract available.